FGF7/FGFR2-JunB signalling counteracts the effect of progesterone in luminal breast cancer.
Mieczkowski K, Kitowska K, Braun M, Galikowska-Bogut B, Gorska-Arcisz M, Piasecka D, Stawiski K, Zaczek AJ, Nejc D, Kordek R, Romanska HM, Sadej R.
Mieczkowski K, et al.
Mol Oncol. 2022 Aug;16(15):2823-2842. doi: 10.1002/1878-0261.13274. Epub 2022 Jul 4.
Mol Oncol. 2022.
PMID: 35726195
Free PMC article.